Comparative effectiveness of guselkumab in psoriatic arthritis: results from systematic literature review and network meta-analysis

Abstract Objective The efficacy of the novel interleukin (IL)-23p19 inhibitor guselkumab for psoriatic arthritis (PsA) has recently been demonstrated in two phase 3 trials (DISCOVER-1 & -2) but has not been evaluated vs other targeted therapies for PsA. The objective was to compare guselkumab to...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Rheumatology (Oxford, England) England), 2021-05, Vol.60 (5), p.2109-2121
Hauptverfasser:	Mease, Philip J, McInnes, Iain B, Tam, Lai-Shan, Eaton, Kiefer, Peterson, Steve, Schubert, Agata, Chakravarty, Soumya D, Parackal, Anna, Karyekar, Chetan S, Nair, Sandhya, Boehncke, Wolf-Henning, Ritchlin, Christopher
Format:	Artikel
Sprache:	eng
Schlagworte:	Systematic Review and Meta-Analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!